Live from the NIH registry
Studies recruiting near Oxnard right now
Top 25 of 133 recruiting studies, sorted by proximity — each links to its official registry page
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
FOMAT - West Coast Research Center — Ventura, California (8.5 mi)
· Sponsor: Duke University
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
UCLA Hematology/Oncology - Ventura — Ventura, California (8.5 mi)
· Sponsor: Pfizer
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Clinical Trials Research Institute — Thousand Oaks, California (19.7 mi)
· Sponsor: Incyte Corporation
Clinical Study of the inQB8 TTVR System (The MonarQ Study)
Tricuspid Valve Regurgitation
N/A
Interventional 50 participants sought
Los Robles Hosptial and Medical Center — Thousand Oaks, California (19.7 mi)
· Sponsor: inQB8 Medical Technologies, LLC
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
Venous Thromboembolism, Metastatic Pancreatic Cancer
Phase 3
Interventional 480 participants sought
Ventura Clinical Trials — Ventura, California (8.5 mi)
· Sponsor: Quercis Pharma AG
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Atrial Fibrillation
N/A
Interventional 276 participants sought
Community Memorial Hospital — Ventura, California (8.5 mi)
· Sponsor: Biosense Webster, Inc.
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 7107 — Thousand Oaks, California (19.7 mi)
· Sponsor: Galderma R&D
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
Difficult to Control Hypertension
Phase 2
Interventional 120 participants sought
Office of Dr. Edward Portnoy MD — Westlake Village, California (21.8 mi)
· Sponsor: E-Star BioTech, LLC
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis, Ulcerative Colitis Chronic
Phase 2
Interventional 143 participants sought
Clinical Trials Management Services, LLC — Thousand Oaks, California (19.7 mi)
· Sponsor: Eli Lilly and Company
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Ventura, California (8.5 mi)
· Sponsor: Medtronic
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
Osteoarthritis
Phase 3
Interventional 800 participants sought
Care Access - Thousand Oaks — Thousand Oaks, California (19.7 mi)
· Sponsor: Eli Lilly and Company
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Crohn Disease
Phase 2
Interventional 60 participants sought
Om Research LLC — Oxnard, California (0.3 mi)
· Sponsor: Eli Lilly and Company
Title: A Multimodal Exercise Program With Gamification for Parkinson Disease (MEP+G)
Parkinson Disease
EARLY/Phase 1
Interventional 50 participants sought
Equilibrium Physical Therapy — Ventura, California (8.5 mi)
· Sponsor: California State University, Northridge
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
Depressive Disorder, Major
Phase 3
Interventional 1,000 participants sought
Accellacare - Moorpark — Moorpark, California (18.2 mi)
· Sponsor: Eli Lilly and Company
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
HER2-negative Breast Cancer Patients With Brain Metastases
Phase 2
Interventional 120 participants sought
FOMAT Medical Research (Network) — Oxnard, California (0.3 mi)
· Sponsor: Biostar Pharma, Inc.
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 36 — Oxnard, California (0.3 mi)
· Sponsor: BioStem Technologies
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
Phase 2
Interventional 372 participants sought
UCLA Hematology/Oncology - Ventura — Ventura, California (8.5 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Acute Ischemic Stroke, Cerebral Stroke
Phase 3
Interventional 514 participants sought
St. John's Regional Medical Center — Oxnard, California (0.3 mi)
· Sponsor: Pharmazz, Inc.
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Episodic Migraine
Phase 3
Interventional 990 participants sought
Clinical Trials Management Services, Merz Investigational Site #0010526 — Thousand Oaks, California (19.7 mi)
· Sponsor: Merz Therapeutics GmbH
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Om Research LLC 2 — Oxnard, California (0.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 1,500 participants sought
Clinical Trials Research Institute /ID# 258021 — Thousand Oaks, California (19.7 mi)
· Sponsor: AbbVie
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1029 — Thousand Oaks, California (19.7 mi)
· Sponsor: Immunovant Sciences GmbH
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12105 — Oxnard, California (0.3 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Care Access Research — Thousand Oaks, California (19.7 mi)
· Sponsor: Novo Nordisk A/S
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400025 — Thousand Oaks, California (19.7 mi)
· Sponsor: Sanofi